On the morning of 4 december, the beijing first-inoculation ceremony for the nine-price national hpv vaccine was launched at the space centre hospital and the first-inoculation for the city of beijing for the nine-price national hpv vaccine was completed. This marked the official launch in beijing of the nine-price hpv vaccine that was developed autonomously。
At the launch site
It is understood that the nine-price hpv vaccine produced in the first home country was developed jointly by xiamen university, the xianning team of shang an innovation laboratories and xiamen wantai long sea biotechnology ltd. Public information indicates that the nine-price national hpv vaccine was developed using the country's first-ever coliform system, which has the advantages of being immunogenic, fast growing, short production cycles, high production and easy to magnify production。
According to pilgrim, the director of gynaecology and gynaecology at beijing university's first hospital, the introduction of the nine-price national hpv vaccine has not only raised the level of biomedical research and development in the country, but has also improved the system for the prevention and control of cervical cancer. It has witnessed china's move from the “power of medicine” to the “power of medicine” and has given us confidence in the goal of “eradication of cervical cancer”。
Studies have shown that the vaccine can effectively protect against diseases such as cervical cancer caused by nine types of hpv infection, with comparable results in immunogenicity and safety compared to imports of the same product. The study demonstrated, through rigorous random control tests, that nationally produced hpv nine-priced vaccines can induce protective neutrals and antibodies at levels similar to those currently on the market, with comparable protective effects. The results were published in the magazine " the lancet infectious diseases " , which was incorporated into the 2023 chinese medical science news。
On december 4th, ms. Zhao (right) was being vaccinated at the space center hospital against the nine-price national hpv vaccine
"there's no difference between fighting this and other vaccines." ms. Zhao, the first inoculated person in beijing, said that the hpv vaccine was still important for women, especially since the introduction of the national vaccine had resulted in a high value for money, and she would recommend it to her friends。
The vaccine is known to apply to women aged 9 to 45 at a single cost of $499. In terms of vaccination procedures, the nine-priced hpv vaccine has been extended to two doses, two doses for women aged 9-17 (0 june) and three doses for women aged 18-45 (0 january and june)。
Currently, beijing city has fully launched the nine-price hpv vaccination service. The first vaccines were delivered on 24 november 2025 to community health service centres throughout the city's districts, where preventive health units are fully prepared to ensure that the vaccinations are carried out in an orderly manner. The population can look at the kyoto micro-procedure, the capital vaccine service app, or direct calls to the local community health centre for vaccination clinics for details, and make appointments for vaccination. (hoco)
